Bruck Pharma is a finished-dose manufacturer based in India. It appears in 11 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with ARCSA (EC) and BRELA (TZ). Its GMP standing is certified by CDSCO (India). Customs aggregates show $1.2M of exports covering 308 molecules to 20 destinations in 2025.
| Site | FDA FEI |
|---|---|
| daman 396 210, India | Not on file |
| Dabhel, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| ARCSA (EC) | 9 | None |
| BRELA (TZ) | 2 | None |
| CDSCO (India) | None | 2 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | Not reported | $1.2M | 20 |
| 2024 | Not reported | $1.2M | 21 |
| 2023 | Not reported | $1.4M | 17 |
| 2022 | Not reported | $1.4M | 19 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Bruck Pharma comes back tiered against every other supplier able to file there.
Start for free